Privia Health Group Inc. (PRVA)
NASDAQ: PRVAHealthcareHealth Information ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 20.30 0.00%
PRVA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.59B
- P/E (TTM)
- 96.67
- Forward P/E
- 19.13
- EPS (TTM)
- $0.21
- Dividend yield
- None
- 52-week range
- 18.92 – 28.82
- Day range
- 20.00 – 20.83
- Volume / Avg
- 1.61M / 1.23M
- Beta
- —
- Shares outstanding
- 127.73M
- Next earnings
- Nov 5, 2026
52-week range
PRVA stock today
Shares of Privia Health Group (PRVA) finished higher on Oct 7 at $20.30, a gain of 0.10% or $0.02 per share, versus the S&P 500's 0.22% decline. Shares are 29.6% below their 52-week high of $28.82, set on Jul 16, 2026 and 7.3% above the 52-week low of $18.92, near the bottom of the past year's range. PRVA is down 14.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 15.5%.
At 96.7x trailing earnings, Privia Health Group trades above the peer-group median of 35.0x. Its forward P/E of 19.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Privia Health Group's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Privia Health Group
Company profilePrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems.
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. Parth Mehrotra
- Headquarters
- Arlington, VA
- Employees
- 1,226
- IPO year
- 2021
- Website
- priviahealth.com
Analyst forecast
ForecastConsensus (18 analysts)
strong_buy
Avg. price target
$31.47+55.02%
- Strong buy 5
- Buy 12
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.09
Privia Health Group peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SDGRSchrodinger Inc. | 27.29 | -5.57% | $2.04B | vs PRVA |
| OMCLOmnicell Inc. | 35.21 | -0.70% | $1.60B | vs PRVA |
| HTFLHeartflow Inc. | 49.36 | -2.62% | $4.29B | vs PRVA |
| DOCSDoximity Inc. Class A | 27.69 | -0.36% | $4.94B | vs PRVA |
| WAYWaystar Holding Corp. | 25.77 | -2.39% | $4.94B | vs PRVA |
| HQYHealthEquity Inc. | 91.90 | +0.93% | $7.60B | vs PRVA |
| HNGEHinge Health Inc. Class A | 97.86 | -0.50% | $7.90B | vs PRVA |
| BTSGBrightSpring Health Services Inc. | 63.80 | +0.08% | $12.62B | vs PRVA |
Indexes, lists and sector
Appears in lists
Privia Health Group stock FAQ
What is Privia Health Group's stock price today?
PRVA last traded at $20.30 as of Oct 7, 4:00 PM EDT, up 0.10% on the day. Prices are delayed at least 15 minutes.
When is Privia Health Group's next earnings date?
Privia Health Group is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.09.
What is PRVA's P/E ratio?
PRVA trades at a trailing P/E ratio of 96.67 and a forward P/E of 19.13, compared with a median of 35.0 for its closest peers.
Who is Privia Health Group's CEO?
Mr. Parth Mehrotra is the chief executive officer of Privia Health Group Inc., which has about 1,226 employees.
What is the PRVA 52-week high?
The 52-week high for PRVA is $28.82 and the 52-week low is $18.92. The stock is currently 29.6% below its high.